Literature DB >> 23079643

Impact of the CXCR4 structure on docking-based virtual screening of HIV entry inhibitors.

Jesús M Planesas1, Violeta I Pérez-Nueno, José I Borrell, Jordi Teixidó.   

Abstract

Herein we analyze in depth the receptor-based virtual screening (VS) performance of the five recent crystallized CXCR4 structures along with a CXCR4 rhodopsin-based homology model. All CXCR4 Protein Data Bank (PDB) structures are co-crystallized with a small organic antagonist except structure 3OE0, which is co-crystallized with a cyclic peptide analog. Evaluation of the CXCR4 models was done by retrospective docking-based VS using a test set of 248 known CXCR4 inhibitors from 4 different chemotype families and 4696 different presumed inactives. The performance of the docking protocol using the five different protein structures was assessed in terms of pose prediction and hits detection using 12 different docking scoring functions and a scoring function with rescoring. Results show that 3OE6 structure achieves the highest docking-based performance with an average area under the curve (aAUC) of 0.84 and an average enrichment factor (aEF) of 11.7 at 1% of decoys screened. CXCR4 rhodopsin-like homology model performs comparable to the crystallized structures in the 1% of database screened. Moreover, a detailed analysis of the retrospective docking results using the CXCR4 homology model in Discovery Studio allows us to hypothesize the existence of multiple binding sub-sites in CXCR4 binding pocket.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23079643     DOI: 10.1016/j.jmgm.2012.06.010

Source DB:  PubMed          Journal:  J Mol Graph Model        ISSN: 1093-3263            Impact factor:   2.518


  7 in total

1.  High glucose enhances HIV entry into T cells through upregulation of CXCR4.

Authors:  Xiqian Lan; Kang Cheng; Nirupama Chandel; Rivka Lederman; Aakash Jhaveri; Mohammad Husain; Ashwani Malhotra; Pravin C Singhal
Journal:  J Leukoc Biol       Date:  2013-08-02       Impact factor: 4.962

Review 2.  Bivalent ligands targeting chemokine receptor dimerization: molecular design and functional studies.

Authors:  Christopher Kent Arnatt; Yan Zhang
Journal:  Curr Top Med Chem       Date:  2014       Impact factor: 3.295

Review 3.  Anti-HIV drug development through computational methods.

Authors:  Wan-Gang Gu; Xuan Zhang; Jun-Fa Yuan
Journal:  AAPS J       Date:  2014-04-24       Impact factor: 4.009

Review 4.  Peptide and protein-based inhibitors of HIV-1 co-receptors.

Authors:  Horst A von Recum; Jonathan K Pokorski
Journal:  Exp Biol Med (Maywood)       Date:  2013-05

5.  Anti-HIV small-molecule binding in the peptide subpocket of the CXCR4:CVX15 crystal structure.

Authors:  Bryan D Cox; Anthony R Prosser; Brooke M Katzman; Ana A Alcaraz; Dennis C Liotta; Lawrence J Wilson; James P Snyder
Journal:  Chembiochem       Date:  2014-07-02       Impact factor: 3.164

6.  Maximal Unbiased Benchmarking Data Sets for Human Chemokine Receptors and Comparative Analysis.

Authors:  Jie Xia; Terry-Elinor Reid; Song Wu; Liangren Zhang; Xiang Simon Wang
Journal:  J Chem Inf Model       Date:  2018-05-08       Impact factor: 4.956

7.  Multi-objective active machine learning rapidly improves structure-activity models and reveals new protein-protein interaction inhibitors.

Authors:  D Reker; P Schneider; G Schneider
Journal:  Chem Sci       Date:  2016-03-10       Impact factor: 9.825

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.